Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D

Loxoscelism is the clinical condition triggered after the bite of spiders of the genus <i>Loxosceles</i>. The main species involved in accidents in South America are <i>L. intermedia</i>, <i>L. laeta,</i> and <i>L. gaucho</i>. The only specific treatme...

Full description

Bibliographic Details
Main Authors: Bruno Cesar Antunes, Nayanne Louise Costacurta Polli, Pedro Henrique de Caires Schluga, Thais Pereira da Silva, Ana Carolina Martins Wille, Rosangela Locatelli-Dittrich, Giovana Scuissiatto de Souza, Fernando Hitomi Matsubara, João Carlos Minozzo, Andrea Senff-Ribeiro, Luiza Helena Gremski, Silvio Sanches Veiga
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/1/79
_version_ 1797445649423138816
author Bruno Cesar Antunes
Nayanne Louise Costacurta Polli
Pedro Henrique de Caires Schluga
Thais Pereira da Silva
Ana Carolina Martins Wille
Rosangela Locatelli-Dittrich
Giovana Scuissiatto de Souza
Fernando Hitomi Matsubara
João Carlos Minozzo
Andrea Senff-Ribeiro
Luiza Helena Gremski
Silvio Sanches Veiga
author_facet Bruno Cesar Antunes
Nayanne Louise Costacurta Polli
Pedro Henrique de Caires Schluga
Thais Pereira da Silva
Ana Carolina Martins Wille
Rosangela Locatelli-Dittrich
Giovana Scuissiatto de Souza
Fernando Hitomi Matsubara
João Carlos Minozzo
Andrea Senff-Ribeiro
Luiza Helena Gremski
Silvio Sanches Veiga
author_sort Bruno Cesar Antunes
collection DOAJ
description Loxoscelism is the clinical condition triggered after the bite of spiders of the genus <i>Loxosceles</i>. The main species involved in accidents in South America are <i>L. intermedia</i>, <i>L. laeta,</i> and <i>L. gaucho</i>. The only specific treatment is the anti-<i>Loxosceles</i> serum produced with crude venoms. As phospholipases D (PLDs) trigger most of the effects observed in accidents, we developed and evaluated second-generation sera using mutated PLDs as antigens. Three isoforms of PLDs with site-directed mutations without biological activities were used for rabbit immunizations: D32A-E34A (<i>L. gaucho</i>), W230A (<i>L. intermedia</i>)<i>,</i> and H12A-H47A (<i>L. laeta</i>). Sera were produced using crude venoms of three species of <i>Loxosceles</i> enriched with mutated recombinant PLDs (MIX) or using only mutated PLDs (REC). Immunizations stimulated the immune system from the second immunization with higher antibody production in the REC group. In vivo neutralization assays demonstrated that both sera reduced edema and dermonecrosis caused by <i>Loxosceles intermedia</i> crude venom. Follow-up of animals during the immunization protocols and in the neutralization assays demonstrated that the mutated proteins and the sera are safe. Results demonstrate the potential of using mutated recombinant PLDs in total or partial replacement of <i>Loxosceles</i> venoms in animal immunizations to produce anti-<i>Loxosceles</i> sera for treatments of Loxoscelism.
first_indexed 2024-03-09T13:29:52Z
format Article
id doaj.art-1536bf20ce2c4f13967d084a6ae98602
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T13:29:52Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-1536bf20ce2c4f13967d084a6ae986022023-11-30T21:19:08ZengMDPI AGBiomedicines2227-90592022-12-011117910.3390/biomedicines11010079Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-DBruno Cesar Antunes0Nayanne Louise Costacurta Polli1Pedro Henrique de Caires Schluga2Thais Pereira da Silva3Ana Carolina Martins Wille4Rosangela Locatelli-Dittrich5Giovana Scuissiatto de Souza6Fernando Hitomi Matsubara7João Carlos Minozzo8Andrea Senff-Ribeiro9Luiza Helena Gremski10Silvio Sanches Veiga11Department of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Structural, Molecular Biology and Genetics, State University of Ponta Grossa (UEPG), Ponta Grossa 84030-900, BrazilVeterinary Hospital, Federal University of Paraná (UFPR), Curitiba 80035-050, BrazilVeterinary Hospital, Federal University of Paraná (UFPR), Curitiba 80035-050, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilProduction and Research Center of Immunobiological Products (CPPI), State Department of Health, Piraquara 83302-200, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilDepartment of Cell Biology, Federal University of Paraná (UFPR), Curitiba 81530-900, BrazilLoxoscelism is the clinical condition triggered after the bite of spiders of the genus <i>Loxosceles</i>. The main species involved in accidents in South America are <i>L. intermedia</i>, <i>L. laeta,</i> and <i>L. gaucho</i>. The only specific treatment is the anti-<i>Loxosceles</i> serum produced with crude venoms. As phospholipases D (PLDs) trigger most of the effects observed in accidents, we developed and evaluated second-generation sera using mutated PLDs as antigens. Three isoforms of PLDs with site-directed mutations without biological activities were used for rabbit immunizations: D32A-E34A (<i>L. gaucho</i>), W230A (<i>L. intermedia</i>)<i>,</i> and H12A-H47A (<i>L. laeta</i>). Sera were produced using crude venoms of three species of <i>Loxosceles</i> enriched with mutated recombinant PLDs (MIX) or using only mutated PLDs (REC). Immunizations stimulated the immune system from the second immunization with higher antibody production in the REC group. In vivo neutralization assays demonstrated that both sera reduced edema and dermonecrosis caused by <i>Loxosceles intermedia</i> crude venom. Follow-up of animals during the immunization protocols and in the neutralization assays demonstrated that the mutated proteins and the sera are safe. Results demonstrate the potential of using mutated recombinant PLDs in total or partial replacement of <i>Loxosceles</i> venoms in animal immunizations to produce anti-<i>Loxosceles</i> sera for treatments of Loxoscelism.https://www.mdpi.com/2227-9059/11/1/79brown spidervenomloxoscelismserum therapyphospholipases D
spellingShingle Bruno Cesar Antunes
Nayanne Louise Costacurta Polli
Pedro Henrique de Caires Schluga
Thais Pereira da Silva
Ana Carolina Martins Wille
Rosangela Locatelli-Dittrich
Giovana Scuissiatto de Souza
Fernando Hitomi Matsubara
João Carlos Minozzo
Andrea Senff-Ribeiro
Luiza Helena Gremski
Silvio Sanches Veiga
Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
Biomedicines
brown spider
venom
loxoscelism
serum therapy
phospholipases D
title Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
title_full Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
title_fullStr Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
title_full_unstemmed Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
title_short Production and Functional Evaluation of Anti-<i>Loxosceles</i> Sera Raised by Immunizations of Rabbits with Mutated Recombinant Phospholipases-D
title_sort production and functional evaluation of anti i loxosceles i sera raised by immunizations of rabbits with mutated recombinant phospholipases d
topic brown spider
venom
loxoscelism
serum therapy
phospholipases D
url https://www.mdpi.com/2227-9059/11/1/79
work_keys_str_mv AT brunocesarantunes productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT nayannelouisecostacurtapolli productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT pedrohenriquedecairesschluga productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT thaispereiradasilva productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT anacarolinamartinswille productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT rosangelalocatellidittrich productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT giovanascuissiattodesouza productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT fernandohitomimatsubara productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT joaocarlosminozzo productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT andreasenffribeiro productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT luizahelenagremski productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd
AT silviosanchesveiga productionandfunctionalevaluationofantiiloxoscelesiseraraisedbyimmunizationsofrabbitswithmutatedrecombinantphospholipasesd